Author: Lynne Taylor

India cuts prices of over 150 life-saving drugs

In the third round of drug price cuts resulting from February’s industry-friendly Union (federal) Budget, the Indian government has announced that the prices of more than 150 life-saving drugs in over 1,000 formulations are to be reduced.

Read More

FDA told: “TV drug ads must include side effects info”

US legislators have asked the Food and Drug Administration to require all television advertisements for prescription drugs to include information on how consumers can report any serious side effects with the advertised drug to the agency, including a toll-free phone number.

Read More

Bonuses “account for 25% of pharma reps’ pay”

Pharmaceutical company representatives who work within the primary care field receive an average of 22% of their total pay in the form of bonuses, while for those working in the speciality care field, the average percentage of salary accounted for by bonus pay is 23%, according to a new study from competitive intelligence firm Cutting Edge Information.

Read More

NICE: still “tallest kid in playground,” but what of future?

Pharmaceutical manufacturers can help the National Institute for Clinical Excellence (NICE) speed up its appraisal of new medicines by providing it with the right information at the right time, NICE’s chairman, Professor Sir Michael Rawlins, told a meeting organised in London by PharmaTimes this week.

Read More